COMBINED DRUG THERAPY OF URETERAL STONES
The analysis of the immediate and long-term results of combined drug therapy ureteral stones (615 patients) was carried out. The age of the patients is from 17 to 82 years, the average age is 47.9 ± 3.7 years, the median is 51.1 years. The men were 310 (50.4%), women - 305 (49.6%). In 317 (51.5%) patients, ureterolithiasis was diagnosed on the left, in 298 (48.5%) on the right. All patients were prescribed myotropic antispasmodics (Drotaverinum), M-cholinolytics (riabal, platyphyllin), superselective alpha blockers (tamsulosin), non-steroidal anti-inflammatory drugs (nimesulide), diuretics (furosemide, torasemide), when prolonged treatment - potassium preparations (asparkam), herbal preparations (cystone, urolesan, madder root extract). During the exacerbation of chronic pyelonephritis, antibiotic therapy was carried out according to the antibioticogram. Stone- free condition was achieved in 547 (88.9%) patients. There was no individual intolerance to drugs, side effects from the gastrointestinal tract, and arterial hypotension. Combined drug therapy of ureteral stones in combination with a water load, including medicinal mineral waters, showed a rather high efficiency (88.9%) and complete safety.